Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00111657
Status:
COMPLETED
Last Update Posted:
2014-10-03
First Post:
2005-05-24
Brief Title:
Pegylated Recombinant Mammalian Uricase PEG-uricase as Treatment for Refractory Gout
Sponsor:
John Sundy
Organization:
Duke University
Organization Data
Organization:
Duke University
Class:
OTHER
Study ID:
Pro00006845
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
John Sundy
Lead Sponsor Class:
OTHER
Responsible Party:
John Sundy
Responsible Party Title:
Associate Professor of Medicine
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Duke University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Savient Pharmaceuticals | INDUSTRY |